Page 3 - Zai Lab Forward News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC

Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesJennifer chang xiaoyu chenRafaelg amadoChristine chiou lina zhangNational medical products administrationZai labBristol myers squibb companyZai lab forwardGlobal oncology researchExchange commissionDrug administrationZai lab limitedBristol myers squibbLab limitedNew england journal

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China s National Reimbursement Drug List

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China s National Reimbursement Drug List
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesJosh smileyWilliam liangChristine chiou lina zhangShaun maccoun xiaoyu chenZai labChina national healthcare security administrationNational reimbursement drug listZai lab limitedZai lab forwardNational medical products administrationExchange commissionParatek pharmaceuticals incLab limitedReimbursement drug list

Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China s National Reimbursement Drug List | Business

SHANGHAI & CAMBRIDGE, Mass. (BUSINESS WIRE) Dec 12, 2023

Hong kongUnited statesWilliam liangJosh smileyChristine chiou lina zhangShaun maccoun xiaoyu chenZai lab limitedChina national healthcare security administrationExchange commissionZai lab forwardNational reimbursement drug listZai labParatek pharmaceuticals incNational medical products administrationLab limitedReimbursement drug list

Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the Center for Drug Evaluation (CDE) of the National

United kingdomHong kongUnited statesHarald reinhartJennifer chang xiaoyu chenChristine chiou lina zhangNational medical products administrationZai lab limitedHead of global developmentZai labZai lab forwardChina international nonproprietary nameExchange commissionLab limitedDrug evaluationBreakthrough therapy designation

Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China

SHANGHAI, China and CAMBRIDGE, Mass., Sept. 18, 2023 Zai Lab Limited today announced that the Center for Drug Evaluation of the National Medical Products Administration granted Breakthrough.

United statesHong kongUnited kingdomChristine chiou lina zhangJennifer chang xiaoyu chenHarald reinhartZai labExchange commissionHead of global developmentNational medical products administrationZai lab forwardZai lab limitedChina international nonproprietary nameLab limitedDrug evaluationBreakthrough therapy designation